How Biotech ETFs Have Performed During the Valeant Stock Crash

Home › How Biotech ETFs Have Performed During the Valeant Stock Crash

Biotech ETFs have been the focus of many investors this week after Valeant Pharmaceuticals Intl. Inc. shares dropped more than 46% last week.

25.06	Atlantic Tropical Weather Outlook
25.06	Eastern North Pacific Tropical Weather Outlook
25.06	Will there be more air travel chaos this summer?
25.06	Bankruptcy trustee plans to shut down Alex Jones' Infowars
25.06	Eastern North Pacific Tropical Weather Outlook
25.06	Atlantic Tropical Weather Outlook
25.06	The screen tech that can do almost anything
25.06	Criminal charges recommended against Boeing
More »

je.st